spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

12th annual Cold Chain Distribution Conference and Exhibition

Cold Chain Distribution Conference and Exhibition

13-14 December 2017
Copthorne Tara Hotel, London, UK

As the global healthcare industry grows, temperature controlled logistics rapidly evolves along with it. Factors such as the ever-changing regulatory requirements, diverse array of biopharma products entering the markets, and new technology emerging daily, are causing companies to face the challenge of constantly adapting their supply chain processes and staying ahead of the curve.

Responding to the evolution within the industry, SMi is proud to announce the return of its leading 12th annual Cold Chain Distribution event. Returning to London in December, this year's event will remain at the forefront of innovation.

There has been a recent surge in temperature sensitive products entering the supply chain and the need for a streamlined temperature controlled supply chain has never been more important. Cold Chain Distribution 2017 looks at why companies must revisit their logistics, quality, and security procedures implemented to ensure they are keeping pace with this exponential growth. With huge interest from leaders in the field, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Cold Chain Distribution event.

The event will look at the fundamental question of how to keep costs low & quality high, while remaining compliant to global regulations.

 

Key topics for 2017 include:

  • GPS temperature monitoring 
  • Temperature data management 
  • Temperature controlled freight options 
  • GDP Regulatory Requirements
  • Identifying Future Trends


This year's event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers:

  • Tony Wright, CEO, Exelsius 
  • Bob Hayes, Director, SeerPharma (UK)  
  • Chris Wallace, Senior Director - International Supply Chain, Sanofi Genzyme 
  • David Spillett, Key Account Director, World Courier 
  • Mark Edwards, Managing Director, Modalis Ltd.  
  • Amélie Ermel, Production Senior Specialist Associate, Eli Lilly  
  • Stephanie Fitt, Sales Manager UK & Scandinavia, EMBALL'ISO 
  • Stephen Mitchell, Quality Lead Logistics Partnership, GlaxoSmithKline 
  • Umit Kartoglu, Scientist, World Health Organization 
  • Martin  Fitzgerald, Deputy Director General, European Association of Pharmaceutical Full Line-Wholesalers (GIRP) 
  • Glyn Stacey, Director of the UK Stem Cell Bank, National Institute For Biological Standards And Control 
  • Tim Wood, Technical Service Manager, GlaxoSmithKline 
  • Gianpiero Lorusso, Supply Chain Director, Merck S.p.A

12th annual Cold Chain Distribution Conference and Exhibition

13th -14th December 2017

Copthorne Tara Hotel, London, UK

Email: events@smi-online.co.uk

Tel: +44 (0) 207 827 6012

www.coldchain-distribution.com/samedan

 

phone Tel: +44 (0) 207 827 6012
email events@smi-online.co.uk
web www.coldchain-distribution.com/samedan
email Copthorne Tara Hotel, London, UK
 
Print this page
Send to a friend
   
spacer
Industry Events

Outsourcing in Clinical Trials Nordics 2017

10-11 October 2017, Copenhagen, Denmark

Enabling local knowledge-sharing, benchmarking and network-building between Nordic biopharma and device industry peers
More info >>

White Papers

Case Study: Cmed’s Mobile Data Management Solution

Cmed Clinical Services

The trial presented to Cmed was a randomized, double blinded, placebo and active controlled study to evaluate the cardiac safety of multiple doses of [study drug] in health volunteers. The pharmaceutical company, who were into the second year of development of a potential blockbuster compound for the treatment of chronic myelogenous leukaemia (CML), were requested by the FDA to design a trial to provide information on the cardiac safety of different dose levels of the study drug in healthy adult volunteers. The primary objective of the study was specifically to find the maximum tolerated dose before QTc levels became unsafe. All development of the compound was put on hold until the results of this study were submitted to the FDA and approval granted for the compound to progress into full development.
More info >>


News and Press Releases

ASPIRE International Conference 2018: Pre-registration now open!

The ASPIRE international conference is taking place on the 28th February and 1st March 2018 at the Vox Conference Centre in Birmingham. The conference brings together members of the research community including research professionals from the NHS, Clinical Trial Networks and international organisations. The ASPIRE conference will allow delegates to share knowledge and best practise with the focus on enhancing the efficiency and productivity of clinical research across the UK and beyond.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement